Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Operating Leases (2022 - 2025)

Praxis Precision Medicines (PRAX) has 3 years of Operating Leases data on record, last reported at $110000.0 in Q4 2024.

  • For Q4 2024, Operating Leases fell 95.59% year-over-year to $110000.0; the TTM value through Dec 2024 reached $110000.0, down 95.59%, while the annual FY2024 figure was $110000.0, 95.59% down from the prior year.
  • Operating Leases reached $110000.0 in Q4 2024 per PRAX's latest filing, down from $436000.0 in the prior quarter.
  • Across five years, Operating Leases topped out at $3.3 million in Q1 2022 and bottomed at $110000.0 in Q4 2024.
  • Average Operating Leases over 3 years is $1.9 million, with a median of $2.1 million recorded in 2023.
  • Peak YoY movement for Operating Leases: changed 0.0% in 2023, then plummeted 95.59% in 2024.
  • A 3-year view of Operating Leases shows it stood at $2.5 million in 2022, then changed by 0.0% to $2.5 million in 2023, then tumbled by 95.59% to $110000.0 in 2024.
  • Per Business Quant database, its latest 3 readings for Operating Leases were $110000.0 in Q4 2024, $436000.0 in Q3 2024, and $755000.0 in Q2 2024.